Company Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-04 pm EST			5-day change	1st Jan Change
1.450 ^USD	+8.21%		+4.32%	-9.94%

Nov. 04	Neuronetics, Inc., Q3 2025 Earnings Call, Nov 04, 2025
Nov. 04	Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Business description: Neuronetics, Inc.

Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Number of employees: 716

Sales by Activity: Neuronetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
Surgical & Medical Equipment	49.24M	55.31M	65.21M	71.35M	74.89M

See all business segments

Geographical breakdown of sales: Neuronetics, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
United States	47.52M	53.45M	63.41M	69.34M	72.49M
International	1.72M	1.86M	1.8M	2.01M	2.4M

See all geographic segments

Executive Committee: Neuronetics, Inc.

Manager	Title	Age	Since
Keith Sullivan CEO	Chief Executive Officer	66	2020-07-13
Steven Pfanstiel DFI	Director of Finance/CFO	53	2025-07-14
Jeffrey Jones COO	Chief Operating Officer	68	2025-06-18
Cory Anderson CTO	Chief Tech/Sci/R&D Officer	-	2021-02-28
W. Macan CMP	Compliance Officer	52	2020-01-20

See NEURONETICS, INC. governance

Composition of the Board of Directors: Neuronetics, Inc.

Director	Title	Age	Since
Glenn Muir BRD	Director/Board Member	66	2017-06-30
Sheryl Conley BRD	Director/Board Member	64	2019-09-30
Keith Sullivan BRD	Director/Board Member	66	2020-07-13
Robert Cascella CHM	Chairman	70	2021-05-26
Megan Rosengarten BRD	Director/Board Member	48	2021-08-01
Sasha Cucuz BRD	Director/Board Member	48	2024-12-09
Avinash Amin BRD	Director/Board Member	55	2024-12-09

Composition of the Board of Directors

Shareholders: Neuronetics, Inc.

Name	Equities	%	Valuation
Madryn Asset Management LP 31.36 %	20,737,061	31.36 %	55 M $
Jorey Chernett 6.659 %	4,403,498	6.659 %	12 M $
Vanguard Fiduciary Trust Co. 4.283 %	2,832,118	4.283 %	8 M $
BlackRock Advisors LLC 3.327 %	2,199,930	3.327 %	6 M $
UBS Financial Services, Inc. 3.266 %	2,159,905	3.266 %	6 M $

List of NEURONETICS, INC. shareholders

Company details: Neuronetics, Inc.

Neuronetics, Inc.

3222 Phoenixville Pike

19355, Malvern

+610 640 4202

http://www.neurostar.com

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
NEURONETICS, INC.	+8.21%	+4.32%	+23.40%	-76.58%	99.3M
THERMO FISHER SCIENTIFIC, INC.	-0.90%	-3.04%	+8.77%	+2.17%	216B
INTUITIVE SURGICAL, INC.	-0.19%	-0.98%	+3.40%	+108.86%	202B
DANAHER CORPORATION	-0.58%	-0.58%	-3.86%	-17.18%	160B
BOSTON SCIENTIFIC CORPORATION	-0.86%	-3.21%	+7.57%	+109.70%	145B
SIEMENS HEALTHINEERS AG	+1.15%	+0.77%	-16.53%	-15.19%	55.5B
EDWARDS LIFESCIENCES CORPORATION	+2.14%	-1.12%	+15.61%	+12.06%	49.78B
AGILENT TECHNOLOGIES, INC.	-0.63%	-3.92%	+5.79%	-4.72%	41.98B
GE HEALTHCARE TECHNOLOGIES INC.	-1.28%	+2.34%	-0.59%	-	37.59B
RESMED, INC.	+0.03%	-1.38%	+2.31%	+7.99%	36.66B
Average	+0.38%	-0.77%	+4.59%	+14.13%	94.46B
Weighted average by Cap.	+0.20%	-1.70%	+3.41%	+39.02%